![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, March 05, 2017 9:00:32 PM
A convertible note has very little to do with CanChew Plus- it has little to do with AXIM's patent for its delivery method- it has little to do with AXIM building its very own manufacturing facility for its CBD products and it seems it has little to do with AXIM being granted the permission from Health Canada to start a clinical trial on THC and mental illness- and it has nothing to do with the outcome of the trial currently underway for CanChew Plus https://clinicaltrials.gov/ct2/results?term=Canchew+&Search=Search
And it has nothing to do with the attention coming to AXIM- in fact I think you're the only one taking about a convertible note- no one else I know of is. https://www.owler.com/reports/axim-biotechnologies/axim-biotech-announces-the-production-of-canchew-p/1488378720689?utm_source=twitter&utm_medium=social&utm_campaign=sectorNews_Pharmaceuticals
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM